CRP is considered to be a marker of atherosclerotic cardiovascular disease in clinical analysis [19,20], modulating endothelial function in the process of atherogenesis [35]; therefore, we suggest that using CRP to distinguish AFL from the other liver diseases may consider the complication of cardiovascular disease. The gene discussed is CRP; the disease is liver disorder.